1. Home
  2. XTNT vs BLAC Comparison

XTNT vs BLAC Comparison

Compare XTNT & BLAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XTNT
    SELLHOLDBUYas of 2 days ago
  • BLAC
    SELLHOLDBUYas of 4 days ago
  • Stock Information
  • Founded
  • XTNT N/A
  • BLAC 2020
  • Country
  • XTNT United States
  • BLAC United States
  • Employees
  • XTNT N/A
  • BLAC N/A
  • Industry
  • XTNT Biotechnology: Biological Products (No Diagnostic Substances)
  • BLAC
  • Sector
  • XTNT Health Care
  • BLAC
  • Exchange
  • XTNT Nasdaq
  • BLAC NYSE
  • Market Cap
  • XTNT 70.2M
  • BLAC 46.9M
  • IPO Year
  • XTNT N/A
  • BLAC 2023
  • Fundamental
  • Price
  • XTNT $0.48
  • BLAC $11.35
  • Analyst Decision
  • XTNT Strong Buy
  • BLAC
  • Analyst Count
  • XTNT 1
  • BLAC 0
  • Target Price
  • XTNT $3.00
  • BLAC N/A
  • AVG Volume (30 Days)
  • XTNT 178.5K
  • BLAC 676.0
  • Earning Date
  • XTNT 11-12-2024
  • BLAC 01-01-0001
  • Dividend Yield
  • XTNT N/A
  • BLAC N/A
  • EPS Growth
  • XTNT N/A
  • BLAC N/A
  • EPS
  • XTNT N/A
  • BLAC N/A
  • Revenue
  • XTNT $113,862,000.00
  • BLAC N/A
  • Revenue This Year
  • XTNT $31.27
  • BLAC N/A
  • Revenue Next Year
  • XTNT $13.07
  • BLAC N/A
  • P/E Ratio
  • XTNT N/A
  • BLAC N/A
  • Revenue Growth
  • XTNT 45.11
  • BLAC N/A
  • 52 Week Low
  • XTNT $0.33
  • BLAC $10.55
  • 52 Week High
  • XTNT $1.30
  • BLAC $13.40
  • Technical
  • Relative Strength Index (RSI)
  • XTNT 57.35
  • BLAC 50.58
  • Support Level
  • XTNT $0.45
  • BLAC $11.32
  • Resistance Level
  • XTNT $0.58
  • BLAC $11.60
  • Average True Range (ATR)
  • XTNT 0.06
  • BLAC 0.05
  • MACD
  • XTNT 0.01
  • BLAC -0.00
  • Stochastic Oscillator
  • XTNT 51.67
  • BLAC 26.47

Stock Price Comparison Chart: XTNT vs BLAC

XTNT
BLAC
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025012345678910111213XTNT VS BLAC

About XTNT Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.

About BLAC BELLEVUE LIFE SCIENCES ACQ CORP

Bellevue Life Sciences Acquisition Corp is a blank check company.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use